Technical Analysis for HOLX - Hologic, Inc.

Grade Last Price % Change Price Change
grade A 50.0 1.11% 0.55
HOLX closed up 1.11 percent on Tuesday, September 17, 2019, on 1.37 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical HOLX trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
20 DMA Support Bullish 1.11%
Spinning Top Other 0.56%
NR7 Range Contraction 0.56%
NR7-2 Range Contraction 0.56%
Three Weeks Tight Range Contraction 0.56%
Multiple of Ten Bearish Other 0.56%
Shooting Star Candlestick Bearish 0.36%
MACD Bullish Centerline Cross Bullish 0.36%
NR7 Range Contraction 0.36%

Older signals for HOLX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company's Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical MRI breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, and ThinPrep system. The company's GYN Surgical segment offers NovaSure system to treat women with excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; Towerfree Hysteroscopy System for the visualization and inspection of the uterine cavity; Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures; and Adiana system, a procedure for permanent female contraception. Its Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems to perform minimally invasive surgical procedures on a patient's extremities. The company sells its products through direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.
Medicine Medical Specialties Clinical Medicine Imaging Breast Cancer X Ray Surgical Products MRI Breast Surgery Cancer Screening HPV Hybridization Mammography Breast Imaging Diagnostics Medical Imaging Systems
Is HOLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.19
52 Week Low 37.47
Average Volume 1,575,311
200-Day Moving Average 46.176
50-Day Moving Average 49.1894
20-Day Moving Average 49.238
10-Day Moving Average 49.424
Average True Range 0.9114
ADX 12.22
+DI 26.1345
-DI 28.5637
Chandelier Exit (Long, 3 ATRs ) 48.2058
Chandelier Exit (Short, 3 ATRs ) 50.5242
Upper Bollinger Band 50.5688
Lower Bollinger Band 47.9072
Percent B (%b) 0.79
BandWidth 5.405581
MACD Line 0.1221
MACD Signal Line 0.0464
MACD Histogram 0.0757
Fundamentals Value
Market Cap 14.02 Billion
Num Shares 280 Million
EPS 2.68
Price-to-Earnings (P/E) Ratio 18.66
Price-to-Sales 3.49
Price-to-Book 3.63
PEG Ratio 2.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.19
Resistance 3 (R3) 51.12 50.67 50.99
Resistance 2 (R2) 50.67 50.36 50.70 50.92
Resistance 1 (R1) 50.33 50.18 50.50 50.40 50.86
Pivot Point 49.88 49.88 49.96 49.91 49.88
Support 1 (S1) 49.54 49.57 49.71 49.61 49.14
Support 2 (S2) 49.09 49.39 49.12 49.08
Support 3 (S3) 48.75 49.09 49.01
Support 4 (S4) 48.82